Changes in BDNF expression levels and distribution, as well in its receptor, tyrosine kinase type 2 (TrkB), have also been reported in patients and animal models of AD (Schulte-Herbruggen et al., 2008). Here, NTRK2 is linked to Alzheimer disease.